Form 8-K - Current report:
SEC Accession No. 0001104659-24-129001
Filing Date
2024-12-16
Accepted
2024-12-16 17:25:51
Documents
53
Period of Report
2024-12-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431151d1_8k.htm   iXBRL 8-K 40396
2 EXHIBIT 99.1 tm2431151d1_ex99-1.htm EX-99.1 28919
3 EXHIBIT 99.2 tm2431151d1_ex99-2.htm EX-99.2 55433
7 GRAPHIC tm2431151d1_ex99-1img001.jpg GRAPHIC 5172
8 GRAPHIC tm2431151d1_ex99-2img001.jpg GRAPHIC 70780
9 GRAPHIC tm2431151d1_ex99-2img002.jpg GRAPHIC 367329
10 GRAPHIC tm2431151d1_ex99-2img003.jpg GRAPHIC 114389
11 GRAPHIC tm2431151d1_ex99-2img004.jpg GRAPHIC 139973
12 GRAPHIC tm2431151d1_ex99-2img005.jpg GRAPHIC 146405
13 GRAPHIC tm2431151d1_ex99-2img006.jpg GRAPHIC 222572
14 GRAPHIC tm2431151d1_ex99-2img007.jpg GRAPHIC 63994
15 GRAPHIC tm2431151d1_ex99-2img008.jpg GRAPHIC 216054
16 GRAPHIC tm2431151d1_ex99-2img009.jpg GRAPHIC 143114
17 GRAPHIC tm2431151d1_ex99-2img010.jpg GRAPHIC 194941
18 GRAPHIC tm2431151d1_ex99-2img011.jpg GRAPHIC 118890
19 GRAPHIC tm2431151d1_ex99-2img012.jpg GRAPHIC 52785
20 GRAPHIC tm2431151d1_ex99-2img013.jpg GRAPHIC 344081
21 GRAPHIC tm2431151d1_ex99-2img014.jpg GRAPHIC 103482
22 GRAPHIC tm2431151d1_ex99-2img015.jpg GRAPHIC 109972
23 GRAPHIC tm2431151d1_ex99-2img016.jpg GRAPHIC 105310
24 GRAPHIC tm2431151d1_ex99-2img017.jpg GRAPHIC 161338
25 GRAPHIC tm2431151d1_ex99-2img018.jpg GRAPHIC 106329
26 GRAPHIC tm2431151d1_ex99-2img019.jpg GRAPHIC 139949
27 GRAPHIC tm2431151d1_ex99-2img020.jpg GRAPHIC 119199
28 GRAPHIC tm2431151d1_ex99-2img021.jpg GRAPHIC 129914
29 GRAPHIC tm2431151d1_ex99-2img022.jpg GRAPHIC 105868
30 GRAPHIC tm2431151d1_ex99-2img023.jpg GRAPHIC 91009
31 GRAPHIC tm2431151d1_ex99-2img024.jpg GRAPHIC 98444
32 GRAPHIC tm2431151d1_ex99-2img025.jpg GRAPHIC 149803
33 GRAPHIC tm2431151d1_ex99-2img026.jpg GRAPHIC 55117
34 GRAPHIC tm2431151d1_ex99-2img027.jpg GRAPHIC 137277
35 GRAPHIC tm2431151d1_ex99-2img028.jpg GRAPHIC 109704
36 GRAPHIC tm2431151d1_ex99-2img029.jpg GRAPHIC 131919
37 GRAPHIC tm2431151d1_ex99-2img030.jpg GRAPHIC 77067
38 GRAPHIC tm2431151d1_ex99-2img031.jpg GRAPHIC 140617
39 GRAPHIC tm2431151d1_ex99-2img032.jpg GRAPHIC 99809
40 GRAPHIC tm2431151d1_ex99-2img033.jpg GRAPHIC 51860
41 GRAPHIC tm2431151d1_ex99-2img034.jpg GRAPHIC 218325
42 GRAPHIC tm2431151d1_ex99-2img035.jpg GRAPHIC 115948
43 GRAPHIC tm2431151d1_ex99-2img036.jpg GRAPHIC 97341
44 GRAPHIC tm2431151d1_ex99-2img037.jpg GRAPHIC 41318
  Complete submission text file 0001104659-24-129001.txt   6972799

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ewtx-20241216.xsd EX-101.SCH 3021
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ewtx-20241216_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ewtx-20241216_pre.xml EX-101.PRE 22363
55 EXTRACTED XBRL INSTANCE DOCUMENT tm2431151d1_8k_htm.xml XML 3681
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40236 | Film No.: 241552906
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)